The effect of inhaled corticosteroids (ICS) on the risk of osteoporosis and fracture in patients
with chronic obstructive pulmonary disease (COPD) remains uncertain. The aim of this study …

BACKGROUND: There are disputes whether inhaled corticosteroids (ICS) increase the
incidence of fracture or osteoporosis among patients with COPD. The aim of this meta …

Background It is uncertain whether long-term use of inhaled corticosteroids (ICSs), widely
used to treat COPD, increases the risk of fracture, particularly in women, in view of the …

Background: Inhaled corticosteroids are used increasingly to treat people with COPD, but
the extent to which these drugs increase the risk of fracture is unclear. Aim: To quantify the …

Background The effect of inhaled corticosteroids (ICS) on fracture risk in patients with
chronic obstructive pulmonary disease (COPD) remains uncertain. The aim of this study was …

Chronic obstructive pulmonary disease (COPD) is characterized by airflow limitation and
osteoporosis is the major comorbidity associated with poor prognosis in COPD. However …

Patients with chronic obstructive pulmonary disease (COPD) are frequently treated with
inhaled corticosteroids (ICS). However, the impact of ICS use on fracture risk remains …

Background Whether the use of inhaled corticosteroids (ICSs) in patients with COPD can
protect from osteoporosis remains undetermined. The aim of this study is to assess the …

Patients with chronic obstructive pulmonary disease (COPD) demonstrate a greater
osteoporosis prevalence than the general population. This osteoporosis risk may be …

Introduction Chronic obstructive pulmonary disease (COPD) is characterised by persistent
airflow obstruction and respiratory symptoms. While short course systemic GCs are …